Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
出版年份 2013 全文链接
标题
Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
作者
关键词
-
出版物
BLOOD
Volume 121, Issue 10, Pages 1720-1728
出版商
American Society of Hematology
发表日期
2013-01-12
DOI
10.1182/blood-2012-07-443770
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: An international study of 264 patients
- (2012) Veronika Buxhofer-Ausch et al. AMERICAN JOURNAL OF HEMATOLOGY
- Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort
- (2012) P. J. Campbell et al. BLOOD
- Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
- (2011) A. Carobbio et al. BLOOD
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms
- (2011) L. Boiocchi et al. JOURNAL OF CLINICAL PATHOLOGY
- Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
- (2011) G Finazzi et al. LEUKEMIA
- Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia
- (2011) Luigi Gugliotta et al. LEUKEMIA RESEARCH
- Pulsatile tinnitus as a first symptom of essential thrombocythemia
- (2010) Haruka Okazaki et al. AMERICAN JOURNAL OF OTOLARYNGOLOGY
- Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
- (2009) T. Barbui et al. BLOOD
- Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation
- (2009) Petro E. Petrides et al. CLINICAL THERAPEUTICS
- JAK2V617F allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis
- (2009) Kais Hussein et al. EXPERIMENTAL HEMATOLOGY
- Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy
- (2009) Peter J. Campbell et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
- (2008) F. Passamonti et al. HAEMATOLOGICA
- Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia
- (2008) Alessandra Carobbio et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More